HighTower Advisors LLC cut its position in shares of Relx Plc (NYSE:RELX – Free Report) by 4.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 107,830 shares of the technology company’s stock after selling 5,251 shares during the quarter. HighTower Advisors LLC’s holdings in Relx were worth $4,898,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. CENTRAL TRUST Co grew its stake in Relx by 1,290.2% in the 4th quarter. CENTRAL TRUST Co now owns 570 shares of the technology company’s stock worth $26,000 after acquiring an additional 529 shares during the period. Versant Capital Management Inc acquired a new position in Relx in the fourth quarter valued at $31,000. Sierra Ocean LLC acquired a new position in Relx in the fourth quarter valued at $43,000. Private Trust Co. NA lifted its position in Relx by 119.9% during the third quarter. Private Trust Co. NA now owns 1,038 shares of the technology company’s stock worth $49,000 after buying an additional 566 shares during the period. Finally, Whipplewood Advisors LLC acquired a new stake in Relx in the 4th quarter worth about $74,000. Institutional investors and hedge funds own 15.02% of the company’s stock.
Relx Stock Performance
Relx stock opened at $49.31 on Thursday. The company has a market cap of $91.51 billion, a price-to-earnings ratio of 26.51, a price-to-earnings-growth ratio of 2.73 and a beta of 0.90. Relx Plc has a 12 month low of $40.25 and a 12 month high of $51.99. The company has a debt-to-equity ratio of 1.46, a current ratio of 0.52 and a quick ratio of 0.47. The stock’s 50-day moving average is $49.04 and its 200-day moving average is $47.65.
Relx Increases Dividend
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on the stock. Barclays upgraded shares of Relx from an “equal weight” rating to an “overweight” rating in a report on Friday, March 14th. StockNews.com downgraded shares of Relx from a “buy” rating to a “hold” rating in a research note on Tuesday, March 4th. Finally, Redburn Atlantic assumed coverage on shares of Relx in a research note on Wednesday, January 8th. They set a “buy” rating for the company.
Check Out Our Latest Analysis on RELX
Relx Profile
RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.
Recommended Stories
- Five stocks we like better than Relx
- Are Penny Stocks a Good Fit for Your Portfolio?
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- What Are Growth Stocks and Investing in Them
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding RELX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Relx Plc (NYSE:RELX – Free Report).
Receive News & Ratings for Relx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relx and related companies with MarketBeat.com's FREE daily email newsletter.